Skip to main content

Veradermics, Inc 8-K, filed Nov 10, 2026

Veradermics, Inc (MANE)

8-K 2026-11-10 For: 2026-11-10
View Original
Added on November 10, 2026

About this 8-K

Veradermics, Inc filed this 8-K on November 10, 2026.

Veradermics reported a third-quarter net loss of $21.0 million, versus $20.1 million a year earlier, with $798.4 million in cash and marketable securities. It also announced positive 12-month topline data from Study '302' for VDPHL01 in men. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits